FindTrial
Sign In

A Study to measure the effects of ketamine magnesium sulphate and both on pain after breast cancer surgery when given during surgery

A study on the effects of intraoperative ketamine magnesium sulphate and both on post operative pain for modified radical mastectomies - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/059068
Enrollment
100
Registered
2023-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Joe John Chirayath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Electively posted cases for modified radical mastectomy. 2)ASA 1 and 2

Exclusion criteria

Exclusion criteria: 1)Patients with history of drug allergy to any of studied drugs . 2)Patients with difficulty in communication and pregnancy. 3)Patients with significant liver renal and cardiac disease 4)Morbid obesity ( BMI >40)

Design outcomes

Primary

MeasureTime frame
To assess and compare the effects of intravenous administration of 0.3mg/kg ketamine ,30mg/kg magnesium sulphate and 0.3mg/kg ketamine and 30mg/kg magnesium sulphate on postoperative pain and analgesic requirements in postoperative patients undergoing Modified Radical mastectomy surgeryTimepoint: Every 4 hrly till upto 12hrs postoperative.—

Secondary

MeasureTime frame
Any incidence of adverse events like sedation,hallucinations, emergence delirium, nausea ,vomiting,arrhythmiasTimepoint: Every 4 hrly till up to 12 hrs postoperative.—

Countries

India

Contacts

Public ContactDr Christa George

Amala Institute Of Medical Sciences

christageorge20@gmail.com7012489203

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026